...BRCA1/2 genetic result. We analyzed potential predictors for pathological anxiety and variables associated to the variat...
...BRCA1/2 mutation carriers, have a high risk of ovarian cancer and metachronous breast cancer. Treatment-focused genetic ...
...BRCA1 (c.3112G→T, c.5251C→T), one BRCA2 (c.4027A→G), two BARD1 (C557S) and four TP53 germline mutations (g.18508_18761de...
...BRCA1 or BRCA2 mutations have better survival than women with ovarian cancer and no mutation. Potential reasons for this...
...BRCA1/2 are the fundamental defects in hereditary ovarian cancer that expresses a distinct phenotype of high response ra...
...BRCA1 gene in Greek breast cancer patients. They have been reported previously six and three times, respectively, in unr...
...BRCA1-defective tumor progression, phenotype of BRCA1-defective cancers, role of BRCA1 in other cancers and finally at w...
...BRCA1/2 analysis.,Segments of exons 11 of BRCA1/2 open reading frames were PCR amplified from either blood derived genom...
...BRCA1 and BRCA2 (BRCAs) genes is a time-consuming and costly procedure that demands faster and cheaper alternative metho...
...BRCA1 and BRCA2 mutation carriers, received niraparib daily at ten escalating doses from 30 mg to 400 mg in a 21-day cyc...
Contact
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
WeChat Official Account
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: product@genelibs.com
Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2
